Deucravacitinib (Sotyktu™) for plaque psoriasis
Research output: Contribution to journal › Letter › Research › peer-review
Standard
Deucravacitinib (Sotyktu™) for plaque psoriasis. / Granau, Agnete Marie; Boye, Theresa Louise; Jensen, Kim Bak; Nielsen, Ole Haagen.
In: Trends in Pharmacological Sciences, Vol. 44, No. 4, 2023, p. 252-253.Research output: Contribution to journal › Letter › Research › peer-review
Harvard
Granau, AM, Boye, TL, Jensen, KB & Nielsen, OH 2023, 'Deucravacitinib (Sotyktu™) for plaque psoriasis', Trends in Pharmacological Sciences, vol. 44, no. 4, pp. 252-253. https://doi.org/10.1016/j.tips.2023.01.004
APA
Granau, A. M., Boye, T. L., Jensen, K. B., & Nielsen, O. H. (2023). Deucravacitinib (Sotyktu™) for plaque psoriasis. Trends in Pharmacological Sciences, 44(4), 252-253. https://doi.org/10.1016/j.tips.2023.01.004
Vancouver
Granau AM, Boye TL, Jensen KB, Nielsen OH. Deucravacitinib (Sotyktu™) for plaque psoriasis. Trends in Pharmacological Sciences. 2023;44(4):252-253. https://doi.org/10.1016/j.tips.2023.01.004
Author
Bibtex
@article{cba3437bbc5e4f969721403955b5574b,
title = "Deucravacitinib (Sotyktu{\texttrademark}) for plaque psoriasis",
author = "Granau, {Agnete Marie} and Boye, {Theresa Louise} and Jensen, {Kim Bak} and Nielsen, {Ole Haagen}",
year = "2023",
doi = "10.1016/j.tips.2023.01.004",
language = "English",
volume = "44",
pages = "252--253",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Ltd. * Trends Journals",
number = "4",
}
RIS
TY - JOUR
T1 - Deucravacitinib (Sotyktu™) for plaque psoriasis
AU - Granau, Agnete Marie
AU - Boye, Theresa Louise
AU - Jensen, Kim Bak
AU - Nielsen, Ole Haagen
PY - 2023
Y1 - 2023
U2 - 10.1016/j.tips.2023.01.004
DO - 10.1016/j.tips.2023.01.004
M3 - Letter
C2 - 36841716
VL - 44
SP - 252
EP - 253
JO - Trends in Pharmacological Sciences
JF - Trends in Pharmacological Sciences
SN - 0165-6147
IS - 4
ER -
ID: 337393242